229 related articles for article (PubMed ID: 33622859)
1. Controversies in the Management of Early-stage Serous Endometrial Cancer.
Larish A; Mariani A; Langstraat C
In Vivo; 2021; 35(2):671-680. PubMed ID: 33622859
[TBL] [Abstract][Full Text] [Related]
2. Early stage uterine serous carcinoma: management updates and genomic advances.
Fader AN; Santin AD; Gehrig PA
Gynecol Oncol; 2013 Apr; 129(1):244-50. PubMed ID: 23321062
[TBL] [Abstract][Full Text] [Related]
3. Monitoring Treatment Response, Early Recurrence, and Survival in Uterine Serous Carcinoma and Carcinosarcoma Patients Using Personalized Circulating Tumor DNA Biomarkers.
Bellone S; McNamara B; Mutlu L; Demirkiran C; Hartwich TMP; Harold J; Yang-Hartwich Y; Siegel ER; Santin AD
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240216
[TBL] [Abstract][Full Text] [Related]
4. Population-based treatment and outcomes of Stage I uterine serous carcinoma.
van der Putten LJ; Hoskins P; Tinker A; Lim P; Aquino-Parsons C; Kwon JS
Gynecol Oncol; 2014 Jan; 132(1):61-4. PubMed ID: 24219983
[TBL] [Abstract][Full Text] [Related]
5. Defining the Optimal Treatment Strategy in Patients With Uterine Serous Carcinoma.
Donkers H; Reijnen C; Galaal K; Lombaers MS; Snijders M; Kraayenbrink AA; Forrest J; Wilkinson R; Dubey S; Norris T; Bekkers R; Pijnenborg JMA; McGrane J
Clin Oncol (R Coll Radiol); 2023 Feb; 35(2):e199-e205. PubMed ID: 36509615
[TBL] [Abstract][Full Text] [Related]
6. Is a More Comprehensive Surgery Necessary in Patients With Uterine Serous Carcinoma?
Touhami O; Trinh XB; Gregoire J; Sebastianelli A; Renaud MC; Grondin K; Plante M
Int J Gynecol Cancer; 2015 Sep; 25(7):1266-70. PubMed ID: 26067862
[TBL] [Abstract][Full Text] [Related]
7. [Diagnosis, treatment and prognosis of uterine serous carcinoma].
Zhang F; Deng LS; Li B; Huang MN; Li XG; Zhang R; Wu LY
Zhonghua Fu Chan Ke Za Zhi; 2020 Dec; 55(12):848-856. PubMed ID: 33355760
[No Abstract] [Full Text] [Related]
8. Novel targeted therapies in uterine serous carcinoma, an aggressive variant of endometrial cancer.
Menderes G; Clark M; Santin AD
Discov Med; 2016 Apr; 21(116):293-303. PubMed ID: 27232515
[TBL] [Abstract][Full Text] [Related]
9. The comparison of pure uterine serous carcinoma and mixed tumor with serous component: a single-institution review of 91 cases.
You X; Dong Y; Wang J; Cheng Y; Jia Y; Zhang X; Wang J
BMC Cancer; 2024 Jan; 24(1):99. PubMed ID: 38233757
[TBL] [Abstract][Full Text] [Related]
10. Executive summary of the American Radium Society appropriate use criteria for management of uterine clear cell and serous carcinomas.
Sherertz T; Jhingran A; Biagioli M; Gaffney D; Elshaikh M; Coleman RL; Harkenrider M; Kidd EA; Jolly S; Yashar C; Portelance L; Wahl A; Venkatesan A; Li L; Small W;
Int J Gynecol Cancer; 2022 Dec; 32(12):1549-1554. PubMed ID: 36423958
[TBL] [Abstract][Full Text] [Related]
11. Comparison of outcomes in early stage uterine carcinosarcoma and uterine serous carcinoma.
Desai NB; Kollmeier MA; Makker V; Levine DA; Abu-Rustum NR; Alektiar KM
Gynecol Oncol; 2014 Oct; 135(1):49-53. PubMed ID: 25084509
[TBL] [Abstract][Full Text] [Related]
12. Minimal uterine serous carcinoma: current concepts in diagnosis and prognosis.
Rabban JT; Zaloudek CJ
Pathology; 2007 Feb; 39(1):125-33. PubMed ID: 17365828
[TBL] [Abstract][Full Text] [Related]
13. HER2 in uterine serous carcinoma: Current state and clinical perspectives.
Navarro Sanchez JM; Finkelman BS; Turner BM; Katerji H; Wang X; Varghese S; Wang T; Peng Y; Hicks DG; Zhang H
Am J Clin Pathol; 2023 Oct; 160(4):341-351. PubMed ID: 37267036
[TBL] [Abstract][Full Text] [Related]
14. Early stage papillary serous or clear cell carcinoma confined to or involving an endometrial polyp: outcomes with and without adjuvant therapy.
Chang-Halpenny CN; Natarajan S; Hwang-Graziano J
Gynecol Oncol; 2013 Dec; 131(3):598-603. PubMed ID: 24135679
[TBL] [Abstract][Full Text] [Related]
15. Impact of adjuvant treatment on outcome in high-risk early-stage endometrial cancer: a retrospective three-center study.
Helpman L; Perri T; Lavee N; Hag-Yahia N; Chariski HA; Kalfon S; Derazne E; Beiner ME; Kadan Y; Fishman A; Korach J; Covens A; Gien L
Int J Gynecol Cancer; 2019 Jan; 29(1):133-139. PubMed ID: 30640695
[TBL] [Abstract][Full Text] [Related]
16. Prognostic factors for patients with early-stage uterine serous carcinoma without adjuvant therapy.
Tate K; Yoshida H; Ishikawa M; Uehara T; Ikeda SI; Hiraoka N; Kato T
J Gynecol Oncol; 2018 May; 29(3):e34. PubMed ID: 29533019
[TBL] [Abstract][Full Text] [Related]
17. Clinical outcomes of adjuvant chemotherapy and vaginal brachytherapy with or without pelvic radiation for surgical stage I-II uterine serous carcinoma.
Robbins JR; Siddiqui MS; Al-Wahab Z; Laser B; Lu M; Ali-Fehmi R; Munkarah A; Elshaikh MA
Eur J Gynaecol Oncol; 2012; 33(5):449-54. PubMed ID: 23185785
[TBL] [Abstract][Full Text] [Related]
18. Clinical Significance of Positive Pelvic Washings in Uterine Papillary Serous Carcinoma Confined to an Endometrial Polyp.
Hanley KZ; Fadare O; Fisher KE; Atkins KA; Mosunjac MB
Int J Gynecol Pathol; 2016 May; 35(3):249-55. PubMed ID: 26535985
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant therapy of uterine clear cell carcinoma: a review.
Xu Y; Hanna RK; Elshaikh MA
Arch Gynecol Obstet; 2016 Mar; 293(3):485-92. PubMed ID: 26626183
[TBL] [Abstract][Full Text] [Related]
20. Comparison of outcomes in early-stage uterine clear cell carcinoma and serous carcinoma.
Zhang M; Yang TJ; Desai NB; DeLair D; Kollmeier MA; Makker V; Leitao MM; Abu-Rustum NR; Alektiar KM
Brachytherapy; 2019; 18(1):38-43. PubMed ID: 30316723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]